BTW, the insider, Dr. Srini Akkaraju, M.D., Ph.D., who acquired almost 1M shares over a week ago, is actually the primary founder of Samsara BioCapital, an Biotech investment firm just filed with SEC in March/2017 with an initial $300M capital. Detailed info can be found via this link
https://www.sec.gov/Archives/edgar/data/1699737/000169973717000003/xslFormDX01/primary_doc.xml
Prior to the crash BioCapital/Dr. Srini Akkaraju had already invested $14M in Versartis (purchased almost 1.5M shares at $12.25). With the doctor's medical background, I think the investor should have a very good knowledge about Somavaratan and decided to put that large amount of money in Versartis. And with the recent purchases, there is a high chance that BioCapital will acquire VSAR.
Also some other Samsara initial investments:
https://www.businesswire.com/news/home/20170421005129/en/Syros-Announces-35-Million-Private-Placement
GLTA
FEATURED Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • BLOZF • May 7, 2024 8:51 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM